MedPath

A study comparing Hypofractionated Radiotherapy (HART) with Conventional Fractionated Radiotherapy (CFRT) in Newly Diagnosed High Grade Glioma (HGG)

Phase 2
Conditions
Health Condition 1: C719- Malignant neoplasm of brain, unspecified
Registration Number
CTRI/2024/03/064914
Lead Sponsor
Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Histologically confirmed cases of high grade gliomas: Anaplastic Astrocytoma (Grade 3), Astrocytoma (grade 4), Glioblastoma (Grade 4)

2. Age = 18 years

3. KPS = 70

4. Adequate renal, hepatic and hematologic function

5. Patients willing to participate in the study

Exclusion Criteria

1. Pregnancy

2. Previous history of chemoradiation

3. Other primary, recurrent or metastatic disease

4. Patients with significant life-threatening co-morbidities

5. History of acute or chronic liver disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath